Answers are grounded in this paper and cite their sources.
Vandetanib demonstrated therapeutic efficacy in a phase III trial of patients with advanced MTC (ClinicalTrials.gov NCT00410761).
No takes yet. Share an insight, caveat, or question.
Wells et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: